Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia-Reference-Cited by-同舟云学术

Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia

Published:2018-05-24 Issue:1 Volume:54 Page:68-75
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Kato Motohiro^ORCID,Kurata Mio,Kanda Junya^ORCID,Kato Koji,Tomizawa Daisuke^ORCID,Kudo Kazuko,Yoshida Nao,Watanabe Kenichiro,Shimada Hiroyuki,Inagaki Jiro,Koh Katsuyoshi,Goto Hiroaki,Kato Keisuke,Cho Yuko,Yuza Yuki,Ogawa Atsushi,Okada Keiko,Inoue Masami,Hashii Yoshiko,Teshima Takanori,Murata Makoto,Atsuta Yoshiko

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-018-0221-6.pdf

Reference20 articles.

1. Storb R, Gyurkocza B, Storer BE, Sorror ML, Blume K, Niederwieser D, et al. Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation. J Clin Oncol. 2013;31:1530–8.

2. Stern M, de Wreede LC, Brand R, van Biezen A, Dreger P, Mohty M, et al. Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis. Leukemia. 2014;28:2235–40.

3. Inagaki J, Fukano R, Noguchi M, Okamura J. A single-center analysis of chronic graft-versus-host disease-free, relapse-free survival after alternative donor stem cell transplantation in children with hematological malignancies. Int J Hematol. 2017; 105:676–85.

4. Pulsipher MA, Langholz B, Wall DA, Schultz KR, Bunin N, Carroll WL, et al. The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children’s Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial. Blood 2014;123:2017–25.

5. Locatelli F, Zecca M, Messina C, Rondelli R, Lanino E, Sacchi N, et al. Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors. Leukemia. 2002;16:2228–37.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Graft-Versus-Host Disease on Relapse and Nonrelapse Mortality Following Posttransplant Cyclophosphamide-Based Transplantation;Transplantation and Cellular Therapy;2024-09

2. A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD;Transplantation and Cellular Therapy;2024-06

3. The graft versus leukemia effect: donor lymphocyte infusions and cellular therapy;Frontiers in Immunology;2024-03-15

4. La thérapie cellulaire dans tous ses états;Bulletin du Cancer;2024-02

5. Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease;Bone Marrow Transplantation;2023-11-06